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Abstract
Recent reports have described in the pediatric population a new type of hyperinflammatory response manifested
following contact with SARS-CoV-2, with some of the clinical features attributable to Kawasaki disease (KD). The
purpose of this commentary is to remark on a possible recent association between SARS-CoV-2 and KD. Although
today little is known about the etiology of KD, the most accepted hypothesis is that of a probable viral etiology,
therefore, even the SARS-CoV-2 virus could trigger, in genetically predisposed subjects, an exaggerated
inflammatory response that is clinically evident like the one described in KD.
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Background
Kawasaki disease (KD) is a vasculitis of the small and
medium caliber vessels with a preference for coronary ar-
teries and it is the most common cause of heart disease
acquired in children [1]. The diagnosis of KD remains
clinical and there are no specific laboratory tests; the
American Heart Association (AHA) criteria and guidelines
reviewed in 2017 are used [2]. The cause of KD remains
unknown. A careful study connects the seasonality of KD
to tropospheric wind patterns, that provides the transpor-
tation of an agent which, if inhaled by genetically sensitive
children, it triggers the KD immunological cascade. An-
other study suggests new RNA virus infection that enters
the upper respiratory tract [2]. Activation of the innate
immune system is an initial event, with evidence of the ac-
tivation of the interleukin signal pathway (IL-1, IL-6 and
TNF-alpha) [3]. The self-limited nature of the disease
combined with a low rate of recurrence suggests the rota-
tion of T and B memory cells which are protective against
future encounters with the agent of KD [4]. KD has been
reported from more than 60 countries across the world,
around the equator to areas near the poles and is seen in
both hot and cold areas. This confirms that several
infectious agents may trigger the disease in different geo-
graphical areas and seasons [5]. Indeed Turnier et al. in
2015 described that 28% of the positive results were attrib-
utable to rhinovirus/enterovirus, 8.7% due to parainflu-
enza and the remaining pathogens: respiratory syncytial
virus, influenza, adenovirus and human coronavirus
(strains 229E, HKU1, NL63, OC43) were each positive less
than 5% of the time [6].
Main text
Following the outbreak of SARS-CoV-2 infection,
COVID-19 pandemic is emerging as a global health issue.
In this context the scientific community is wondering
about a possible correlation between SARS-CoV-2 virus
infection and the onset of Kawasaki-like diseases. From
studies reported so far, the pediatric population appears to
be affected less than adults. In the last period with the in-
crease in number of infections, there have been first re-
ports of KD secondary to SARS-CoV-2 infection [7], some
typical forms, other atypical ones. Shelley Riphagen et al.
during a 10-day period in mid-April, in the UK, reported a
cluster of 8 children with hyperinflammatory shock syn-
drome. This cluster of cases formed the basis of a national
alarm. They suggest that this clinical picture represents a
new phenomenon that affects previously asymptomatic
children with SARS-CoV-2 infection manifesting itself as
a hyperinflammatory multi-organ involvement syndrome
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similar to a shock syndrome in KD [8]. Kawasaki disease
shock syndrome (KDSS) is characterized by cardiovascular
shock, associated with resistance to immunoglobulins,
coronary anomalies and hyperinflammatory state with
possible cardiovascular shock [9]. In studies of adult pa-
tients with Covid-19, a subset of patients showed hyperin-
flammation and multi-organ failure due to excessive
release of cytokines caused by an uncontrolled immune
response. Similarly, genetically susceptible pediatric pa-
tients, after contact with Covid-19, could develop a disease
complicated by hyperinflammatory shock. KD, as men-
tioned above, is known to recognize infectious triggers,
most often viruses, and SARS-COV 2, which is, at present,
the most common infectious agent in the world, could
probably induce the development of epidemic clusters
outbreaks by KD. The recorded anomaly could be the sig-
nificant percentage of severe KD cases: this could be ex-
plained by the fact that the typical Covid-19 cytokine
storm has a substantial overlap with that of Kawasaki dis-
ease, with high levels of IL-1, IL-6 and TNF-alpha, and
also the presence of circulating activated macrophages
that characterize both the diseases [10].
Conclusions
It is therefore necessary, in order to avoid diagnostic and
therapeutic pitfalls, in the presence of a child with symp-
toms compatible with KD, to exclude an infection with
SARS-CoV-2 virus, even in the presence of an initial
negativity of the search for SARS-CoV-2, through naso-
pharyngeal swab and serological research tests. Of note,
epidemiological studies are awaited in order to avert
overestimated prevalence of KD correlated somehow
with Covid-19 infection. In the meantime several med-
ical societies have issued strict statements with the aim
of either accurate diagnosis and appropriate treatment.
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